| | |
Both the Lok Sabha and the Rajya Sabha were adjourned for the day after an uproar over FDI in multi-brand retail. The Rajya Sabha was also hit by the SC/ST quota issue.
12:07 pm: The Rajya Sabha did not see any work on Day 3 of the winter session on Monday and was adjourned till Tuesday after an uproar over FDI in retail. Meanwhile, the UPA coordination committee will meet allies on Tuesday to discuss the FDI voting provision.
12:05 pm:Both the Lok Sabha and the Rajya Sabha resumed after being adjourned over FDI in retail.
11:14 am: The issue of FDI in multi-brand retail continued to derail Parliament for the third day on Monday as both Houses were adjourned till noon after an uproar over the issue. In the Rajya Sabha, Opposition leaders shouted slogans against FDI.
The government has called an all-party meeting on Monday to break the deadlock. Sources say that as per its strategy it will say executive decisions don't allow vote. It will will ask for sense among political parties at meeting.
Sources say the government will also seek to alienate the Left Front and BJP to show they are the only ones who are asking for a vote. According to sources, the government will say it is ready but only if that's what all parties want.
Meanwhile, the UPA seems to have played the 2G card ahead of the all-party meet to resolve the parliament deadlock on FDI. Congress ally DMK has given a notice for a discussion under rule 193 on the CAG report on 2G Scam in the Lok Sabha. The notice comes after ex-CAG audit officer RP Singh claimed the report was influenced by BJP leader and Public Accounts Committee Chairman Murli Manohar Joshi.
RP Singh alleged that Joshi had called audit officials to his house for preparation of the PAC report on 2G scam that indicted the government. Joshi even offered to resign if the allegations against him could be proved. RP Singh alleged that he was told to sign on the 2010 audit report to Parliament that had estimated a loss of Rs 1.76 lakh crore on account of spectrum sale.
ADS BY GOOGLE
video of the day
Barring IT & pharma, Q2 earnings to disappoint: Dimensions